Discontinuation of anticoagulant therapy for a month in a patient with HeartMate III continuous-flow left ventricular assist device without thromboembolic events: Case Report

Publication date: Available online 9 January 2018 Source:Journal of the Saudi Heart Association Author(s): Abdelfatah Elasfar, Kafaf Jalali, Mohamed Hussein, Ibraheem AlHarbi, Osama Amoudi The recommended anticoagulation regimen for continuous-flow left ventricular assist device (LVAD) systems is warfarin and aspirin with a targeted international normalized ratio (INR) of 2.0–3.0. Our patient is a 58-year-old male who underwent surgical HeartMate III continuous-flow LVAD implantation 3 months ago outside the country. The patient mistakenly stopped his warfarin for one month before presenting to our center for routine visit. Luckily, the patient was doing very well without any complication despite his INR was 1.0.
Source: Journal of the Saudi Heart Association - Category: Cardiology Source Type: research